Sevag N Balikian, MD
Nephrology · Pasadena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 20 years
- Graduated 2006
Offices
1 location · Sevag Balikian, M.D., A Professional Corporation · 2 clinicians in this group
Looking this up.
Hospitals listed: 052613 · 552662 · 552734 · 552787 · 552836 · 059699 · Glendale Adventist Medical Center · Huntington Hospital · USC Arcadia Hospital · 05t238. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Balikian’s office at (626) 352-0010 to ask if they take your plan before you enroll.
California Medical Board record
Licence A105269 · Current
Licensed to practise in California · since 2008 · expires 2028-02-29 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Glendale Adventist Medical CenterGlendale, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.57) · 9,330 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.073, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.277, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Huntington HospitalPasadena, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- USC Arcadia HospitalArcadia, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Southern California, which runs 4 hospitalsPatients rate it 2 of 5 · 62% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.545, Oct 2024 – Sep 2025
See every measure and the patient survey for Glendale Adventist Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.57) · 9,330 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.073 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0.01 to 1.79) · 1,817 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.75 (0.48 to 1.01) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.81 (119.07 to 204.55) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 142 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 312 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.7 · 787 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 1,340 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 352 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,776 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 11,108 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.35) · 11,736 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3 (1.22 to 4.78) · 2,564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.76 (0.19 to 3.33) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.38 (0.04 to 2.71) · 2,540 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.3 (2.34 to 14.26) · 947 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.26 (1.99 to 8.53) · 895 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 112 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.686 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.978 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.234 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.7 · 368 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.2 · 930 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 30.6 · 370 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -4.5 · 1,036 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.9 · 1,549 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.9 · 1,397 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (7.5 to 15.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.9 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 68 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.5) · 183 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 416 cases | No different | Jan 2024 – Dec 2024 |
What patients said (759 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Huntington Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 6 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.68 (0 to 1.56) · 2,225 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 149.43 (106.58 to 192.28) · 128 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.8 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 475 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.7 · 822 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 463 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 5,850 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 10,123 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 10,515 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.4 (2.67 to 6.13) · 2,613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.32 (0 to 2.86) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.44 to 4.11) · 2,457 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.71 (1.95 to 13.48) · 1,211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.08 (0.8 to 7.36) · 1,189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.42 to 3.29) · 825 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0.03 to 1.09) · 8,956 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 269 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.448 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.977 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.423 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 253 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 846 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.2 · 176 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.1 · 542 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.5 · 864 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 1,144 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.2 to 8.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 15.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 260 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 201 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.8 to 15.8) · 365 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 786 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,430 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for USC Arcadia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.545 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.76) · 1,417 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.27 (0.97 to 1.58) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.26 (152.13 to 228.39) · 89 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.6 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 413 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.9 · 432 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 3,815 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,579 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 6,907 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.52 (1.51 to 5.53) · 1,534 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.88 (0.26 to 3.51) · 534 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (0.97 to 3.94) · 1,486 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 15.28 (8.51 to 22.05) · 562 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.95 (4.26 to 11.64) · 512 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.29 (0.81 to 3.77) · 479 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.7 (0.11 to 1.29) · 5,994 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.9 · 285 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.652 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.694 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.145 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 196 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.9 · 487 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 28.1 · 723 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 863 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.4 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 155 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.5 to 16.9) · 408 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 538 cases | No different | Jan 2024 – Dec 2024 |
What patients said (560 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 70% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 77% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 64% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 62% |
| Staff "always" explained possible side effects | 34% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$568,495
Medicare paid this office $568,495 for 813 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 98 | $165,805 | $306 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 388 | $113,191 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 234 | $64,434 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 92 | $45,998 | $256 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 195 | $31,181 | $147 |
See all 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 98 | $165,805 | $306 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 388 | $113,191 | $67 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 234 | $64,434 | $101 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 92 | $45,998 | $256 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 195 | $31,181 | $147 |
| Return visit (30+ min) | 182 | $30,448 | $107 |
| Long return visit (40+ min) | 90 | $25,443 | $156 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 71 | $25,122 | $43 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 69 | $20,864 | $44 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 119 | $15,209 | $111 |
| Dialysis services, 1 physician visit per month (20 years or older) | 36 | $8,596 | $175 |
| New patient visit (45+ min) | 41 | $5,109 | $125 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 43 | $4,638 | $35 |
| Critical care, first 30-74 minutes | 16 | $4,314 | $180 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 12 | $211 | $18 |
Who their Medicare patients are
813 Original Medicare patients in 2024. Average age 76 · Under 65 13% · 85 and older 27% · Women 49% · Also on Medicaid 68% · Health risk score 4.17. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 70% · Coronary heart disease 63% · Heart failure 60% · Depression 38% · Atrial fibrillation 35% · COPD 33% · Dementia 29% · Stroke 20% · Cancer 18%.
The office billed $1,367,165, Medicare allowed $716,498 and paid $568,495; for 5,313 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 813 | 5,313 | 76 | 4.17 | $1,367,165 | $568,495 |
| 2023 | 710 | 4,493 | 76 | 4.40 | $1,329,875 | $557,469 |
| 2022 | 637 | 3,923 | 75 | 3.66 | $1,257,393 | $534,259 |
| 2021 | 588 | 3,818 | 75 | 4.00 | $1,188,036 | $505,596 |
| 2020 | 582 | 3,630 | 76 | 3.81 | $1,129,173 | $425,938 |
| 2019 | 568 | 3,364 | 75 | 4.59 | $1,129,017 | $417,818 |
| 2018 | 456 | 3,363 | 75 | 4.27 | $990,346 | $378,175 |
| 2017 | 480 | 3,738 | 76 | 3.79 | $971,526 | $376,069 |
| 2016 | 307 | 2,576 | 74 | 4.40 | $744,892 | $279,029 |
| 2015 | 260 | 2,316 | 75 | 4.47 | $716,658 | $275,311 |
| 2014 | 312 | 2,110 | 77 | 3.86 | $624,761 | $243,621 |
| 2013 | 331 | 1,194 | 77 | 3.09 | $266,975 | $123,882 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 107 | $252,601 | $297 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 355 | $115,520 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 157 | $45,427 | $99 |
| Return visit (30+ min) | 145 | $23,457 | $98 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 50 | $21,571 | $248 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 148 | $19,115 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 124 | $18,308 | $144 |
| Long return visit (40+ min) | 57 | $13,550 | $141 |
| Dialysis services, 1 physician visit per month (20 years or older) | 37 | $8,240 | $172 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 59 | $7,807 | $46 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 65 | $7,664 | $43 |
| New patient visit (45+ min) | 28 | $3,927 | $140 |
| New patient visit (60+ min) | 23 | $3,627 | $158 |
| Short return visit (20+ min) | 37 | $3,035 | $66 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 62 | $1,097 | $18 |
2022: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 103 | $278,636 | $307 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 311 | $90,093 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 158 | $42,609 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $21,803 | $163 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $19,383 | $255 |
| Home dialysis services per month (20 years or older) | 11 | $18,143 | $256 |
| Return visit (30+ min) | 114 | $16,755 | $101 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 116 | $16,425 | $113 |
| Long return visit (40+ min) | 30 | $9,245 | $147 |
| Short return visit (20+ min) | 88 | $8,996 | $62 |
| New patient visit (45+ min) | 35 | $4,681 | $134 |
| New patient visit (60+ min) | 23 | $4,335 | $188 |
2021: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 101 | $236,582 | $306 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 273 | $89,746 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 170 | $53,546 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 127 | $23,058 | $171 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $22,437 | $255 |
| Home dialysis services per month (20 years or older) | 15 | $21,582 | $254 |
| Short return visit (20+ min) | 124 | $18,147 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 107 | $14,644 | $116 |
| Return visit (30+ min) | 55 | $7,468 | $113 |
| Long return visit (40+ min) | 22 | $6,073 | $156 |
| New patient visit (60+ min) | 26 | $4,857 | $187 |
| New patient visit (45+ min) | 24 | $3,548 | $148 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $2,153 | $166 |
2020: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 84 | $187,739 | $248 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 293 | $75,393 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 185 | $52,454 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 146 | $25,870 | $175 |
| Home dialysis services per month (20 years or older) | 12 | $21,815 | $208 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 30 | $14,475 | $210 |
| Short return visit (20+ min) | 123 | $14,344 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 103 | $13,993 | $118 |
| New patient visit (45+ min) | 39 | $4,506 | $116 |
| Return visit (30+ min) | 49 | $4,405 | $70 |
| Dialysis services, 1 physician visit per month (20 years or older) | 16 | $4,230 | $163 |
| Long return visit (40+ min) | 27 | $2,716 | $78 |
2019: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 91 | $171,021 | $243 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 290 | $73,593 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 173 | $48,903 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 140 | $25,401 | $170 |
| Home dialysis services per month (20 years or older) | 11 | $24,517 | $204 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 34 | $15,987 | $205 |
| Return visit (30+ min) | 102 | $15,573 | $86 |
| Long return visit (40+ min) | 56 | $14,613 | $118 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 99 | $13,554 | $116 |
| New patient visit (45+ min) | 42 | $5,178 | $123 |
| New patient visit (60+ min) | 21 | $3,306 | $157 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $2,705 | $159 |
2018: 14 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 79 | $135,276 | $241 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 186 | $66,865 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 219 | $58,492 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 132 | $24,727 | $169 |
| Home dialysis services per month (20 years or older) | 13 | $19,439 | $198 |
| Return visit (30+ min) | 94 | $14,318 | $82 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 37 | $13,715 | $202 |
| Long return visit (40+ min) | 48 | $12,974 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $9,864 | $113 |
| Critical care, first 30-74 minutes | 18 | $4,874 | $187 |
| Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour | 26 | $4,535 | $91 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $4,292 | $159 |
| New patient visit (60+ min) | 24 | $4,033 | $168 |
| New patient visit (45+ min) | 25 | $2,850 | $114 |
2017: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 57 | $91,760 | $231 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 278 | $81,038 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 207 | $70,031 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 200 | $39,641 | $165 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 119 | $17,831 | $112 |
| Return visit (30+ min) | 110 | $17,477 | $82 |
| Home dialysis services per month (20 years or older) | 12 | $16,507 | $190 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $13,642 | $195 |
| Long return visit (40+ min) | 36 | $9,853 | $119 |
| New patient visit (45+ min) | 42 | $5,268 | $125 |
| Critical care, first 30-74 minutes | 11 | $4,386 | $183 |
| New patient visit (60+ min) | 12 | $2,038 | $170 |
| Short return visit (20+ min) | 29 | $1,940 | $55 |
2016: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 44 | $73,849 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 187 | $72,773 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 183 | $48,406 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 166 | $32,195 | $161 |
| Critical care, first 30-74 minutes | 31 | $12,441 | $183 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 26 | $12,332 | $193 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 53 | $6,626 | $110 |
| Return visit (30+ min) | 28 | $4,332 | $85 |
| New patient visit (45+ min) | 11 | $1,458 | $133 |
2015: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 40 | $69,199 | $237 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 161 | $68,049 | $87 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 162 | $36,250 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 133 | $33,165 | $60 |
| Critical care, first 30-74 minutes | 37 | $27,093 | $187 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $12,888 | $201 |
| Return visit (30+ min) | 55 | $9,871 | $91 |
| Hemodialysis procedure with physician evaluation | 21 | $3,626 | $60 |
| Dialysis services, 1 physician visit per month (20 years or older) | 13 | $2,649 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,183 | $115 |
2014: 9 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $60,225 | $240 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 181 | $59,005 | $86 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $32,648 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 146 | $28,579 | $169 |
| Critical care, first 30-74 minutes | 50 | $26,237 | $182 |
| Return visit (30+ min) | 67 | $16,064 | $92 |
| New patient visit (45+ min) | 36 | $4,889 | $136 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 15 | $4,053 | $203 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,381 | $115 |
2013: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 187 | $31,160 | $58 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 19 | $21,100 | $234 |
| Critical care, first 30-74 minutes | 26 | $15,431 | $177 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 18 | $11,064 | $198 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $10,890 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $8,245 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 70 | $7,651 | $108 |
| Return visit (30+ min) | 31 | $7,182 | $90 |
| New patient visit (45+ min) | 29 | $4,008 | $138 |
| Hospital discharge day management, 30 minutes or less | 26 | $1,541 | $59 |
Medicaid work
$63,764 in 2024
Medicaid paid $63,764 for 1,324 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 297 | $40,217 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 743 | $14,376 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 190 | $4,711 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 24 | $2,526 |
| 1ST HOSP IP/OBS HIGH 75 | 32 | $1,268 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 13 | $297 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 12 | $208 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 13 | $162 |
| 2024 | 1,324 | 8 | 47 | $63,764 |
| 2023 | 1,453 | 5 | 48 | $90,138 |
| 2022 | 1,225 | 3 | 49 | $86,933 |
| 2021 | 1,013 | 3 | 32 | $62,484 |
| 2020 | 264 | 2 | 24 | $22,390 |
| 2019 | 334 | 2 | 21 | $24,349 |
| 2018 | 294 | 2 | 23 | $16,734 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 529 | $73,473 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 859 | $15,591 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 33 | $879 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 16 | $143 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 16 | $51 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 497 | $70,824 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 698 | $15,052 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 30 | $1,058 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 329 | $45,290 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 641 | $15,255 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 43 | $1,939 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 233 | $21,641 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 31 | $748 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 226 | $22,371 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 108 | $1,978 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 205 | $15,808 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 89 | $926 |
Drugs they prescribed that Part D paid
$391,124
Pharmacies billed $391,124 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (32 of 2,068) in 2024. A higher opioid share than 9 in 10 peers; the typical nephrology clinician is at 0%.
1,636 generic and 421 brand-name prescriptions · $391,124 in drug cost · 56 antibiotic prescriptions to 38 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 40 | $110,732 | $2,768 |
| Renvela | 29 | $58,182 | $2,006 |
| Farxiga | 54 | $32,139 | $595 |
| Lokelma | 40 | $28,398 | $710 |
| Januvia | 42 | $23,530 | $560 |
See all 43 drugs
| Velphoro | 40 | $110,732 | $2,768 |
| Renvela | 29 | $58,182 | $2,006 |
| Farxiga | 54 | $32,139 | $595 |
| Lokelma | 40 | $28,398 | $710 |
| Januvia | 42 | $23,530 | $560 |
| Sevelamer Carbonate | 92 | $16,220 | $176 |
| Eliquis | 23 | $13,930 | $606 |
| Clinolipid | 28 | $10,843 | $387 |
| Jardiance | 14 | $8,191 | $585 |
| Prosol | 44 | $5,916 | $134 |
| Calcium Acetate | 39 | $3,923 | $101 |
| Terazosin | 122 | $2,132 | $17 |
| Hydralazine | 129 | $1,497 | $12 |
| Sodium Polystyrene Sulfonate | 12 | $1,215 | $101 |
| Febuxostat | 13 | $1,190 | $92 |
| Midodrine | 16 | $1,099 | $69 |
| Nifedipine Er | 45 | $1,034 | $23 |
| Clonidine | 13 | $898 | $69 |
| Clonidine | 98 | $676 | $7 |
| Amlodipine Besylate | 172 | $564 | $3 |
| Carvedilol | 80 | $326 | $4 |
| Calcitriol | 13 | $321 | $25 |
| Hydrocodone-Acetaminophen | 15 | $278 | $19 |
| Tamsulosin | 57 | $261 | $5 |
| Candesartan Cilexetil | 11 | $250 | $23 |
| Fluconazole | 13 | $243 | $19 |
| Furosemide | 86 | $240 | $3 |
| Atorvastatin | 40 | $195 | $5 |
| Solifenacin | 12 | $178 | $15 |
| Zolpidem | 14 | $172 | $12 |
| Losartan | 65 | $146 | $2 |
| Irbesartan | 19 | $120 | $6 |
| Lisinopril | 27 | $111 | $4 |
| Prednisone | 28 | $107 | $4 |
| Metoprolol | 29 | $105 | $4 |
| Olmesartan Medoxomil | 19 | $89 | $5 |
| Allopurinol | 24 | $88 | $4 |
| Colchicine | 11 | $85 | $8 |
| Ciprofloxacin | 28 | $76 | $3 |
| Metoprolol | 35 | $60 | $2 |
| Montelukast | 12 | $38 | $3 |
| Azithromycin | 13 | $30 | $2 |
| Tramadol | 17 | $29 | $2 |
Year by year
| 2024 | 2,068 | 191 | 2% (32) | 20% | $391,124 |
| 2023 | 2,265 | 206 | 2% (40) | 17% | $440,786 |
| 2022 | 2,605 | 209 | 2% (53) | 18% | $514,050 |
| 2021 | 2,793 | 202 | 2% (49) | 21% | $541,931 |
| 2020 | 3,011 | 200 | 2% (63) | 24% | $597,593 |
| 2019 | 3,169 | 192 | 2% (66) | 21% | $503,914 |
| 2018 | 3,290 | 187 | 2% (50) | 20% | $566,046 |
| 2017 | 3,115 | 164 | 1% (41) | 27% | $577,101 |
| 2016 | 2,383 | 133 | 1% (17) | 32% | $414,435 |
| 2015 | 1,527 | 91 | None | 31% | $224,527 |
| 2014 | 906 | 67 | None | 29% | $129,142 |
| 2013 | 422 | 67 | None | None | $53,921 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 57 drugs
| Velphoro | 37 | $109,940 | $2,971 |
| Renvela | 44 | $74,612 | $1,696 |
| Sevelamer Carbonate | 95 | $32,918 | $347 |
| Cinacalcet | 24 | $29,717 | $1,238 |
| Lokelma | 35 | $28,644 | $818 |
| Januvia | 34 | $23,135 | $680 |
| Eliquis | 30 | $17,870 | $596 |
| Restasis | 14 | $9,765 | $698 |
| Farxiga | 16 | $9,381 | $586 |
| Sps | 23 | $9,254 | $402 |
| Vascepa | 13 | $4,981 | $383 |
| Febuxostat | 23 | $4,974 | $216 |
| Clonidine | 27 | $4,871 | $180 |
| Prograf | 16 | $4,518 | $282 |
| Calcium Acetate | 31 | $3,419 | $110 |
| Midodrine | 20 | $3,278 | $164 |
| Terazosin | 168 | $3,208 | $19 |
| Prosol | 18 | $2,562 | $142 |
| Hydralazine | 111 | $2,123 | $19 |
| Sodium Polystyrene Sulfonate | 31 | $1,998 | $64 |
| Nifedipine Er | 46 | $1,673 | $36 |
| Amlodipine Besylate | 184 | $1,542 | $8 |
| Losartan | 71 | $1,020 | $14 |
| Tamsulosin | 50 | $937 | $19 |
| Clonidine | 67 | $848 | $13 |
| Veo Insulin | 14 | $751 | $54 |
| Carvedilol | 69 | $655 | $9 |
| Furosemide | 108 | $554 | $5 |
| Allopurinol | 50 | $507 | $10 |
| Diclofenac | 14 | $469 | $34 |
| Hydrocodone-Acetaminophen | 20 | $450 | $22 |
| Irbesartan | 22 | $430 | $20 |
| Atorvastatin | 33 | $404 | $12 |
| Metoprolol | 45 | $401 | $9 |
| Candesartan Cilexetil | 12 | $386 | $32 |
| Solifenacin | 13 | $327 | $25 |
| Prednisone | 35 | $275 | $8 |
| Fluticasone Propionate | 14 | $270 | $19 |
| Levothyroxine | 15 | $217 | $14 |
| Ciprofloxacin | 35 | $201 | $6 |
| Minoxidil | 13 | $194 | $15 |
| Omeprazole | 11 | $167 | $15 |
| Montelukast | 18 | $162 | $9 |
| Trazodone | 11 | $161 | $15 |
| Zolpidem | 16 | $160 | $10 |
| Calcitriol | 11 | $158 | $14 |
| Tramadol | 20 | $131 | $7 |
| Ezetimibe | 13 | $131 | $10 |
| Olmesartan Medoxomil | 18 | $129 | $7 |
| Metoprolol | 16 | $116 | $7 |
| Potassium Chloride | 11 | $111 | $10 |
| Triamcinolone Acetonide | 13 | $110 | $8 |
| Bumetanide | 14 | $108 | $8 |
| Rosuvastatin | 13 | $93 | $7 |
| Hydrochlorothiazide | 21 | $85 | $4 |
| Alprazolam | 13 | $82 | $6 |
| Azithromycin | 12 | $80 | $7 |
2022: 64 drugs
| Renvela | 71 | $111,170 | $1,566 |
| Velphoro | 42 | $97,680 | $2,326 |
| Sevelamer Carbonate | 105 | $53,290 | $508 |
| Januvia | 32 | $19,054 | $595 |
| Eliquis | 30 | $16,880 | $563 |
| Lokelma | 15 | $11,805 | $787 |
| Sps | 31 | $10,300 | $332 |
| Cinacalcet | 13 | $9,463 | $728 |
| Restasis | 12 | $8,373 | $698 |
| Midodrine | 16 | $8,309 | $519 |
| Retacrit | 13 | $5,659 | $435 |
| Calcium Acetate | 36 | $5,449 | $151 |
| Vascepa | 12 | $4,601 | $383 |
| Tobradex | 16 | $4,038 | $252 |
| Prosol | 22 | $3,090 | $140 |
| Nifedipine Er | 62 | $2,636 | $43 |
| Novolin 70-30 | 12 | $2,636 | $220 |
| Terazosin | 155 | $2,573 | $17 |
| Febuxostat | 15 | $2,486 | $166 |
| Clonidine | 15 | $2,135 | $142 |
| Sodium Polystyrene Sulfonate | 39 | $1,838 | $47 |
| Lactulose | 17 | $1,757 | $103 |
| Hydralazine | 123 | $1,531 | $12 |
| Ventolin Hfa | 21 | $1,222 | $58 |
| Solifenacin | 11 | $1,060 | $96 |
| Rosuvastatin | 30 | $780 | $26 |
| Olopatadine | 14 | $772 | $55 |
| Carvedilol | 89 | $758 | $9 |
| Amlodipine-Atorvastatin | 11 | $746 | $68 |
| Hydrocodone-Acetaminophen | 26 | $721 | $28 |
| Amlodipine Besylate | 183 | $648 | $4 |
| Clonidine | 111 | $625 | $6 |
| Atorvastatin | 53 | $558 | $11 |
| Losartan | 98 | $554 | $6 |
| Sodium Citrate-Citric Acid | 11 | $508 | $46 |
| Furosemide | 130 | $439 | $3 |
| Veo Insulin | 11 | $432 | $39 |
| Tamsulosin | 44 | $395 | $9 |
| Allopurinol | 62 | $392 | $6 |
| Candesartan Cilexetil | 12 | $350 | $29 |
| Irbesartan | 18 | $339 | $19 |
| Fluticasone Propionate | 24 | $267 | $11 |
| Clopidogrel | 17 | $262 | $15 |
| Potassium Chloride | 24 | $229 | $10 |
| Levothyroxine | 17 | $220 | $13 |
| Minoxidil | 13 | $209 | $16 |
| Omeprazole | 35 | $193 | $6 |
| Metoprolol | 32 | $148 | $5 |
| Montelukast | 24 | $143 | $6 |
| Metoprolol | 15 | $134 | $9 |
| Gabapentin | 28 | $130 | $5 |
| Triamcinolone Acetonide | 12 | $119 | $10 |
| Ciprofloxacin | 30 | $110 | $4 |
| Prednisone | 17 | $106 | $6 |
| Tramadol | 27 | $103 | $4 |
| Azithromycin | 16 | $96 | $6 |
| Zolpidem | 24 | $77 | $3 |
| Hydrochlorothiazide | 22 | $72 | $3 |
| Trazodone | 16 | $56 | $4 |
| Ezetimibe | 12 | $45 | $4 |
| Alprazolam | 14 | $32 | $2 |
| Methimazole | 13 | $30 | $2 |
| Ondansetron | 13 | $29 | $2 |
| Alendronate | 13 | $18 | $1 |
2021: 61 drugs
| Velphoro | 72 | $192,950 | $2,680 |
| Renvela | 77 | $106,170 | $1,379 |
| Sevelamer Carbonate | 119 | $29,024 | $244 |
| Januvia | 38 | $20,069 | $528 |
| Humalog Kwikpen U-100 | 17 | $15,839 | $932 |
| Auryxia | 16 | $14,708 | $919 |
| Eliquis | 25 | $13,071 | $523 |
| Sps | 41 | $11,247 | $274 |
| Restasis | 13 | $8,448 | $650 |
| Cinacalcet | 13 | $7,905 | $608 |
| Calcium Acetate | 56 | $7,633 | $136 |
| Prosol | 50 | $6,802 | $136 |
| Prograf | 20 | $5,882 | $294 |
| Toujeo Solostar | 14 | $5,067 | $362 |
| Vascepa | 13 | $4,743 | $365 |
| Febuxostat | 16 | $4,552 | $284 |
| Nifedipine Er | 99 | $4,040 | $41 |
| Tobradex | 13 | $3,139 | $241 |
| Lactulose | 27 | $2,066 | $77 |
| Midodrine | 20 | $2,033 | $102 |
| Sodium Polystyrene Sulfonate | 25 | $1,546 | $62 |
| Amiodarone | 11 | $1,411 | $128 |
| Terazosin | 85 | $1,303 | $15 |
| Hydralazine | 112 | $1,226 | $11 |
| Rosuvastatin | 50 | $1,152 | $23 |
| Potassium Chloride | 26 | $1,096 | $42 |
| Ventolin Hfa | 19 | $1,070 | $56 |
| Carvedilol | 131 | $1,023 | $8 |
| Amlodipine Besylate | 204 | $819 | $4 |
| Losartan | 88 | $793 | $9 |
| Hydrocodone-Acetaminophen | 21 | $563 | $27 |
| Furosemide | 145 | $562 | $4 |
| Atorvastatin | 34 | $526 | $15 |
| Omega-3 Acid Ethyl Esters | 16 | $517 | $32 |
| Clonidine | 100 | $459 | $5 |
| Candesartan Cilexetil | 12 | $457 | $38 |
| Allopurinol | 51 | $422 | $8 |
| Levothyroxine | 30 | $363 | $12 |
| Clopidogrel | 33 | $337 | $10 |
| Fluticasone Propionate | 25 | $281 | $11 |
| Tamsulosin | 33 | $276 | $8 |
| Triamcinolone Acetonide | 19 | $238 | $13 |
| Metoprolol | 22 | $221 | $10 |
| Lidocaine-Prilocaine | 19 | $217 | $11 |
| Nystatin | 13 | $186 | $14 |
| Zolpidem | 46 | $185 | $4 |
| Minoxidil | 13 | $182 | $14 |
| Omeprazole | 42 | $162 | $4 |
| Pantoprazole | 19 | $154 | $8 |
| Glipizide Er | 12 | $151 | $13 |
| Metoprolol | 34 | $145 | $4 |
| Gabapentin | 32 | $120 | $4 |
| Prednisone | 15 | $111 | $7 |
| Ciprofloxacin | 29 | $82 | $3 |
| Tramadol | 28 | $81 | $3 |
| Montelukast | 15 | $63 | $4 |
| Losartan-Hydrochlorothiazide | 12 | $53 | $4 |
| Ondansetron | 15 | $38 | $3 |
| Hydrochlorothiazide | 21 | $30 | $1 |
| Methimazole | 12 | $27 | $2 |
| Alendronate | 12 | $17 | $1 |
2020: 67 drugs
| Velphoro | 68 | $159,859 | $2,351 |
| Renvela | 57 | $81,871 | $1,436 |
| Sevelamer Carbonate | 104 | $44,613 | $429 |
| Auryxia | 13 | $35,589 | $2,738 |
| Januvia | 37 | $22,220 | $601 |
| Lokelma | 16 | $17,066 | $1,067 |
| Eliquis | 32 | $17,065 | $533 |
| Restasis | 12 | $7,275 | $606 |
| Prograf | 24 | $6,853 | $286 |
| Cinacalcet | 11 | $6,590 | $599 |
| Sodium Polystyrene Sulfonate | 56 | $6,018 | $107 |
| Toujeo Solostar | 19 | $5,908 | $311 |
| Colcrys | 12 | $5,797 | $483 |
| Nifedipine Er | 121 | $5,332 | $44 |
| Sps | 35 | $4,491 | $128 |
| Calcium Acetate | 54 | $4,288 | $79 |
| Midodrine | 35 | $3,867 | $110 |
| Epogen | 22 | $3,784 | $172 |
| Tobradex | 12 | $3,783 | $315 |
| Prosol | 32 | $3,751 | $117 |
| Nitroglycerin | 11 | $2,633 | $239 |
| Rosuvastatin | 33 | $2,395 | $73 |
| Fluconazole | 18 | $2,088 | $116 |
| Ventolin Hfa | 27 | $1,662 | $62 |
| Hydralazine | 70 | $1,138 | $16 |
| Amlodipine Besylate | 227 | $868 | $4 |
| Potassium Chloride | 28 | $853 | $30 |
| Lactulose | 15 | $825 | $55 |
| Carvedilol | 127 | $796 | $6 |
| Clonidine | 96 | $757 | $8 |
| Furosemide | 158 | $728 | $5 |
| Losartan | 83 | $717 | $9 |
| Atorvastatin | 38 | $682 | $18 |
| Candesartan Cilexetil | 13 | $606 | $47 |
| Terazosin | 46 | $535 | $12 |
| Allopurinol | 66 | $513 | $8 |
| Levothyroxine | 29 | $413 | $14 |
| Pantoprazole | 32 | $342 | $11 |
| Zolpidem | 50 | $332 | $7 |
| Clopidogrel | 40 | $314 | $8 |
| Lidocaine-Prilocaine | 26 | $292 | $11 |
| Hydroxyzine | 12 | $287 | $24 |
| Metoprolol | 31 | $259 | $8 |
| Fluticasone Propionate | 27 | $253 | $9 |
| Omeprazole | 58 | $245 | $4 |
| Ondansetron | 17 | $244 | $14 |
| Prednisone | 31 | $242 | $8 |
| Gabapentin | 43 | $217 | $5 |
| Montelukast | 19 | $213 | $11 |
| Alprazolam | 11 | $212 | $19 |
| Famotidine | 17 | $208 | $12 |
| Lisinopril | 16 | $207 | $13 |
| Hydrocodone-Acetaminophen | 20 | $195 | $10 |
| Tamsulosin | 18 | $151 | $8 |
| Glipizide Er | 12 | $148 | $12 |
| Escitalopram | 30 | $143 | $5 |
| Ciprofloxacin | 43 | $143 | $3 |
| Triamcinolone Acetonide | 17 | $125 | $7 |
| Azithromycin | 28 | $123 | $4 |
| Simvastatin | 27 | $123 | $5 |
| Tramadol | 43 | $114 | $3 |
| Metoprolol | 36 | $96 | $3 |
| Hydrochlorothiazide | 39 | $78 | $2 |
| Metoclopramide | 11 | $63 | $6 |
| Alendronate | 14 | $36 | $3 |
| Glipizide | 11 | $36 | $3 |
| Methimazole | 14 | $35 | $3 |
2019: 73 drugs
| Velphoro | 49 | $135,007 | $2,755 |
| Renvela | 66 | $94,766 | $1,436 |
| Sevelamer Carbonate | 73 | $46,782 | $641 |
| Procrit | 15 | $26,864 | $1,791 |
| Januvia | 22 | $15,175 | $690 |
| Eliquis | 29 | $15,057 | $519 |
| Sensipar | 17 | $13,859 | $815 |
| Novolog Flexpen | 17 | $13,574 | $798 |
| Restasis | 14 | $7,896 | $564 |
| Prograf | 24 | $6,853 | $286 |
| Calcium Acetate | 61 | $5,266 | $86 |
| Nifedipine Er | 104 | $3,432 | $33 |
| Sodium Polystyrene Sulfonate | 40 | $3,302 | $83 |
| Nitroglycerin | 19 | $2,984 | $157 |
| Midodrine | 32 | $2,473 | $77 |
| Tacrolimus | 24 | $2,195 | $91 |
| Mycophenolate Mofetil | 13 | $1,523 | $117 |
| Fluconazole | 15 | $1,491 | $99 |
| Amlodipine Besylate | 262 | $1,457 | $6 |
| Ventolin Hfa | 25 | $1,420 | $57 |
| Hydralazine | 79 | $1,412 | $18 |
| Sps | 20 | $1,311 | $66 |
| Furosemide | 216 | $1,008 | $5 |
| Gentamicin Sulfate | 14 | $991 | $71 |
| Prosol | 12 | $968 | $81 |
| Carvedilol | 126 | $950 | $8 |
| Terazosin | 69 | $863 | $13 |
| Atorvastatin | 49 | $767 | $16 |
| Allopurinol | 73 | $711 | $10 |
| Losartan | 104 | $708 | $7 |
| Clonidine | 103 | $701 | $7 |
| Rosuvastatin | 25 | $661 | $26 |
| Potassium Chloride | 33 | $617 | $19 |
| Voltaren | 11 | $604 | $55 |
| Ultra-Fine Nano Pen Needle | 11 | $512 | $47 |
| Doxazosin Mesylate | 11 | $469 | $43 |
| Metoprolol | 24 | $341 | $14 |
| Ciprofloxacin | 33 | $332 | $10 |
| Megestrol Acetate | 14 | $318 | $23 |
| Fluticasone Propionate | 26 | $318 | $12 |
| Escitalopram | 44 | $316 | $7 |
| Lidocaine-Prilocaine | 25 | $311 | $12 |
| Omeprazole | 48 | $300 | $6 |
| Oxybutynin Chloride Er | 12 | $297 | $25 |
| Metolazone | 20 | $294 | $15 |
| Alprazolam | 20 | $290 | $15 |
| Prednisone | 40 | $263 | $7 |
| Clopidogrel | 35 | $262 | $7 |
| Gabapentin | 48 | $256 | $5 |
| Ondansetron | 20 | $249 | $12 |
| Hydrocodone-Acetaminophen | 21 | $238 | $11 |
| Tamsulosin | 30 | $226 | $8 |
| Famotidine | 17 | $223 | $13 |
| Lisinopril | 22 | $221 | $10 |
| Perindopril Erbumine | 11 | $208 | $19 |
| Zolpidem | 43 | $204 | $5 |
| Triamcinolone Acetonide | 23 | $186 | $8 |
| Metoprolol | 57 | $183 | $3 |
| Mupirocin | 12 | $173 | $14 |
| Pantoprazole | 25 | $173 | $7 |
| Montelukast | 13 | $161 | $12 |
| Finasteride | 12 | $159 | $13 |
| Azithromycin | 25 | $144 | $6 |
| Tramadol | 42 | $139 | $3 |
| Lactulose | 13 | $134 | $10 |
| Spironolactone | 28 | $132 | $5 |
| Methimazole | 13 | $120 | $9 |
| Simvastatin | 18 | $112 | $6 |
| Temazepam | 13 | $107 | $8 |
| Indapamide | 11 | $85 | $8 |
| Alendronate | 13 | $58 | $4 |
| Hydrochlorothiazide | 23 | $45 | $2 |
| Fluoxetine | 12 | $22 | $2 |
2018: 71 drugs
| Renvela | 91 | $159,475 | $1,752 |
| Velphoro | 25 | $79,115 | $3,165 |
| Sevelamer Carbonate | 81 | $76,380 | $943 |
| Procrit | 16 | $27,064 | $1,691 |
| Sensipar | 26 | $21,242 | $817 |
| Eliquis | 43 | $19,208 | $447 |
| Novolog Flexpen | 20 | $17,579 | $879 |
| Lantus Solostar | 28 | $10,696 | $382 |
| Calcium Acetate | 100 | $8,388 | $84 |
| Advair Diskus | 12 | $6,290 | $524 |
| Restasis | 11 | $5,683 | $517 |
| Dexilant | 12 | $3,332 | $278 |
| Nitroglycerin | 20 | $3,143 | $157 |
| Clonidine | 28 | $2,720 | $97 |
| Kionex | 38 | $2,433 | $64 |
| Nifedipine Er | 87 | $2,310 | $27 |
| Esomeprazole Magnesium | 23 | $2,176 | $95 |
| Hydralazine | 117 | $1,643 | $14 |
| Mycophenolate Mofetil | 13 | $1,541 | $119 |
| Tacrolimus | 18 | $1,512 | $84 |
| Sodium Polystyrene Sulfonate | 22 | $1,439 | $65 |
| Midodrine | 25 | $1,147 | $46 |
| Clonidine | 135 | $964 | $7 |
| Ultra-Fine Nano Pen Needle | 13 | $944 | $73 |
| Atorvastatin | 82 | $929 | $11 |
| Amlodipine Besylate | 200 | $894 | $4 |
| Allopurinol | 68 | $868 | $13 |
| Carvedilol | 165 | $866 | $5 |
| Furosemide | 202 | $842 | $4 |
| Isosorbide Mononitrate Er | 36 | $780 | $22 |
| Terazosin | 83 | $758 | $9 |
| Rosuvastatin | 26 | $744 | $29 |
| Megestrol Acetate | 26 | $734 | $28 |
| Gabapentin | 42 | $713 | $17 |
| Doxazosin Mesylate | 11 | $705 | $64 |
| Losartan | 123 | $702 | $6 |
| Voltaren | 12 | $657 | $55 |
| Tamsulosin | 45 | $501 | $11 |
| Olmesartan Medoxomil | 13 | $480 | $37 |
| Potassium Chloride | 23 | $382 | $17 |
| Oxybutynin Chloride Er | 14 | $362 | $26 |
| Alprazolam | 32 | $361 | $11 |
| Zolpidem | 61 | $361 | $6 |
| Labetalol | 12 | $295 | $25 |
| Levothyroxine | 12 | $291 | $24 |
| Metolazone | 16 | $290 | $18 |
| Lidocaine-Prilocaine | 12 | $264 | $22 |
| Metoprolol | 72 | $258 | $4 |
| Polyethylene Glycol 3350 | 15 | $254 | $17 |
| Valsartan | 13 | $243 | $19 |
| Clopidogrel | 41 | $231 | $6 |
| Hydrocodone-Acetaminophen | 18 | $207 | $11 |
| Omeprazole | 43 | $202 | $5 |
| Lisinopril | 30 | $176 | $6 |
| Escitalopram | 33 | $159 | $5 |
| Prednisone | 32 | $143 | $4 |
| Pantoprazole | 26 | $141 | $5 |
| Finasteride | 12 | $137 | $11 |
| Tramadol | 31 | $127 | $4 |
| Triamcinolone Acetonide | 15 | $117 | $8 |
| Ondansetron | 13 | $116 | $9 |
| Ciprofloxacin | 28 | $116 | $4 |
| Temazepam | 12 | $114 | $9 |
| Azithromycin | 18 | $102 | $6 |
| Metoclopramide | 15 | $100 | $7 |
| Famotidine | 16 | $98 | $6 |
| Montelukast | 11 | $75 | $7 |
| Methimazole | 11 | $58 | $5 |
| Alendronate | 11 | $40 | $4 |
| Simvastatin | 11 | $29 | $3 |
| Hydrochlorothiazide | 18 | $23 | $1 |
2017: 73 drugs
| Renvela | 154 | $233,172 | $1,514 |
| Sensipar | 95 | $131,820 | $1,388 |
| Velphoro | 20 | $40,049 | $2,002 |
| Procrit | 16 | $23,362 | $1,460 |
| Calcium Acetate | 114 | $13,174 | $116 |
| Eliquis | 25 | $10,053 | $402 |
| Novolog Flexpen | 11 | $9,908 | $901 |
| Nexium | 24 | $6,149 | $256 |
| Lantus | 15 | $5,993 | $400 |
| Advair Diskus | 12 | $5,817 | $485 |
| Lantus Solostar | 17 | $5,368 | $316 |
| Januvia | 11 | $4,291 | $390 |
| Dexilant | 12 | $3,124 | $260 |
| Nasonex | 12 | $3,008 | $251 |
| Sodium Polystyrene Sulfonate | 29 | $2,800 | $97 |
| Kionex | 34 | $2,259 | $66 |
| Nifedipine Er | 82 | $1,962 | $24 |
| Hydralazine | 97 | $1,563 | $16 |
| Atorvastatin | 77 | $1,153 | $15 |
| Tamsulosin | 53 | $1,103 | $21 |
| Isosorbide Mononitrate Er | 37 | $1,092 | $30 |
| Clonidine | 142 | $952 | $7 |
| Nitroglycerin | 24 | $897 | $37 |
| Midodrine | 16 | $841 | $53 |
| Carvedilol | 173 | $819 | $5 |
| Furosemide | 189 | $757 | $4 |
| Ventolin Hfa | 14 | $749 | $53 |
| Allopurinol | 74 | $722 | $10 |
| Potassium Citrate Er | 12 | $698 | $58 |
| Losartan | 111 | $677 | $6 |
| Amlodipine Besylate | 137 | $662 | $5 |
| Voltaren | 12 | $629 | $52 |
| Megestrol Acetate | 15 | $550 | $37 |
| Potassium Chloride | 35 | $530 | $15 |
| Valsartan | 24 | $512 | $21 |
| Rosuvastatin | 12 | $507 | $42 |
| Terazosin | 40 | $438 | $11 |
| Levothyroxine | 26 | $438 | $17 |
| Ondansetron | 27 | $408 | $15 |
| Oxybutynin Chloride Er | 15 | $397 | $26 |
| Metoprolol | 30 | $363 | $12 |
| Lisinopril | 54 | $354 | $7 |
| Sucralfate | 12 | $338 | $28 |
| Doxazosin Mesylate | 12 | $317 | $26 |
| Gabapentin | 47 | $304 | $6 |
| Calcitriol | 13 | $291 | $22 |
| Polyethylene Glycol 3350 | 15 | $277 | $18 |
| Pantoprazole | 32 | $259 | $8 |
| Hydrocodone-Acetaminophen | 21 | $216 | $10 |
| Prednisone | 30 | $211 | $7 |
| Metoprolol | 58 | $207 | $4 |
| Escitalopram | 27 | $176 | $7 |
| Clopidogrel | 25 | $170 | $7 |
| Valsartan-Hydrochlorothiazide | 12 | $168 | $14 |
| Ciprofloxacin | 32 | $163 | $5 |
| Omeprazole | 31 | $149 | $5 |
| Verapamil Er | 13 | $135 | $10 |
| Spironolactone | 15 | $135 | $9 |
| Alprazolam | 19 | $134 | $7 |
| Azithromycin | 28 | $131 | $5 |
| Torsemide | 11 | $124 | $11 |
| Zolpidem | 30 | $123 | $4 |
| Finasteride | 12 | $122 | $10 |
| Mirtazapine | 11 | $116 | $11 |
| Montelukast | 12 | $93 | $8 |
| Atenolol | 23 | $87 | $4 |
| Tramadol | 20 | $81 | $4 |
| Metoclopramide | 16 | $77 | $5 |
| Hydrochlorothiazide | 24 | $69 | $3 |
| Methimazole | 12 | $62 | $5 |
| Famotidine | 24 | $53 | $2 |
| Lovastatin | 12 | $53 | $4 |
| Alendronate | 12 | $37 | $3 |
2016: 58 drugs
| Renvela | 150 | $203,741 | $1,358 |
| Sensipar | 49 | $41,440 | $846 |
| Procrit | 26 | $30,130 | $1,159 |
| Velphoro | 18 | $17,450 | $969 |
| Novolog Flexpen | 25 | $11,852 | $474 |
| Nexium | 34 | $8,650 | $254 |
| Januvia | 21 | $7,784 | $371 |
| Eliquis | 21 | $7,569 | $360 |
| Calcium Acetate | 79 | $7,420 | $94 |
| Lantus Solostar | 25 | $6,780 | $271 |
| Lantus | 13 | $3,989 | $307 |
| Combivent Respimat | 12 | $3,838 | $320 |
| Spiriva | 11 | $3,709 | $337 |
| Dexilant | 12 | $2,923 | $244 |
| Nasonex | 11 | $2,665 | $242 |
| Nifedipine Er | 51 | $1,302 | $26 |
| Tamsulosin | 47 | $1,203 | $26 |
| Proair Hfa | 20 | $1,097 | $55 |
| Midodrine | 12 | $1,017 | $85 |
| Bd Ultra-Fine Pen Needle | 26 | $959 | $37 |
| Hydralazine | 75 | $883 | $12 |
| Isosorbide Mononitrate Er | 34 | $877 | $26 |
| Atorvastatin | 61 | $748 | $12 |
| Metoprolol | 32 | $643 | $20 |
| Tacrolimus | 11 | $621 | $56 |
| Valsartan | 29 | $608 | $21 |
| Amlodipine Besylate | 127 | $503 | $4 |
| Clonidine | 96 | $493 | $5 |
| Losartan | 81 | $486 | $6 |
| Carvedilol | 76 | $469 | $6 |
| Oxybutynin Chloride Er | 15 | $404 | $27 |
| Lidocaine-Prilocaine | 11 | $386 | $35 |
| Nitrostat | 11 | $372 | $34 |
| Allopurinol | 38 | $358 | $9 |
| Furosemide | 127 | $345 | $3 |
| Escitalopram | 46 | $322 | $7 |
| Levothyroxine | 21 | $317 | $15 |
| Sucralfate | 11 | $302 | $27 |
| Potassium Chloride | 16 | $302 | $19 |
| Terazosin | 31 | $284 | $9 |
| Unifine Pentips | 13 | $270 | $21 |
| Ultra Comfort | 12 | $255 | $21 |
| Prednisone | 40 | $236 | $6 |
| Verapamil | 12 | $230 | $19 |
| Metoprolol | 71 | $222 | $3 |
| Gabapentin | 27 | $194 | $7 |
| Lisinopril | 35 | $189 | $5 |
| Pantoprazole | 22 | $188 | $9 |
| Hydrochlorothiazide | 44 | $162 | $4 |
| Temazepam | 12 | $138 | $12 |
| Omeprazole | 20 | $127 | $6 |
| Diazepam | 12 | $92 | $8 |
| Spironolactone | 16 | $77 | $5 |
| Azithromycin | 14 | $75 | $5 |
| Ciprofloxacin | 13 | $50 | $4 |
| Clopidogrel | 11 | $44 | $4 |
| Atenolol | 12 | $42 | $3 |
| Alprazolam | 11 | $24 | $2 |
2015: 41 drugs
| Renvela | 97 | $94,657 | $976 |
| Sensipar | 19 | $12,778 | $673 |
| Nexium | 28 | $6,974 | $249 |
| Lantus | 20 | $5,714 | $286 |
| Calcium Acetate | 30 | $3,752 | $125 |
| Combivent Respimat | 12 | $3,471 | $289 |
| Novolog | 14 | $3,137 | $224 |
| Sodium Polystyrene Sulfonate | 14 | $1,548 | $111 |
| Proair Hfa | 22 | $1,112 | $51 |
| Tacrolimus | 15 | $1,065 | $71 |
| Hydralazine | 63 | $849 | $13 |
| Tamsulosin | 25 | $818 | $33 |
| Amlodipine Besylate | 126 | $674 | $5 |
| Nifedipine Er | 31 | $654 | $21 |
| Ondansetron | 14 | $618 | $44 |
| Bethanechol Chloride | 12 | $611 | $51 |
| Metoprolol | 30 | $571 | $19 |
| Metolazone | 14 | $515 | $37 |
| Insulin | 16 | $488 | $31 |
| Atorvastatin | 30 | $465 | $16 |
| Sucralfate | 14 | $423 | $30 |
| Allopurinol | 30 | $380 | $13 |
| Terazosin | 44 | $362 | $8 |
| Calcitriol | 12 | $332 | $28 |
| Isosorbide Mononitrate Er | 29 | $327 | $11 |
| Furosemide | 61 | $287 | $5 |
| Valsartan | 13 | $272 | $21 |
| Metoprolol | 59 | $230 | $4 |
| Warfarin | 17 | $196 | $12 |
| Valsartan-Hydrochlorothiazide | 13 | $175 | $13 |
| Losartan | 41 | $174 | $4 |
| Clonidine | 44 | $162 | $4 |
| Potassium Chloride | 17 | $161 | $9 |
| Escitalopram | 21 | $148 | $7 |
| Gabapentin | 13 | $115 | $9 |
| Carvedilol | 17 | $111 | $7 |
| Hydrochlorothiazide | 41 | $93 | $2 |
| Lisinopril | 13 | $73 | $6 |
| Diazepam | 12 | $59 | $5 |
| Ciprofloxacin | 13 | $58 | $4 |
| Spironolactone | 12 | $38 | $3 |
2014: 25 drugs
| Renvela | 57 | $51,986 | $912 |
| Sensipar | 17 | $14,945 | $879 |
| Calcium Acetate | 27 | $5,077 | $188 |
| Lantus | 18 | $4,045 | $225 |
| Combivent Respimat | 12 | $3,336 | $278 |
| Nexium | 13 | $3,159 | $243 |
| Amlodipine Besylate | 93 | $796 | $9 |
| Hydralazine | 29 | $701 | $24 |
| Metoprolol | 22 | $651 | $30 |
| Terazosin | 50 | $559 | $11 |
| Insulin | 16 | $480 | $30 |
| Warfarin | 24 | $427 | $18 |
| Clopidogrel | 16 | $356 | $22 |
| Tamsulosin | 15 | $348 | $23 |
| Levothyroxine | 15 | $269 | $18 |
| Isosorbide Mononitrate Er | 19 | $261 | $14 |
| Carvedilol | 23 | $259 | $11 |
| Atorvastatin | 21 | $247 | $12 |
| Allopurinol | 21 | $160 | $8 |
| Lisinopril | 24 | $160 | $7 |
| Furosemide | 32 | $154 | $5 |
| Losartan | 15 | $145 | $10 |
| Hydrochlorothiazide | 21 | $81 | $4 |
| Diazepam | 13 | $57 | $4 |
| Metoprolol | 11 | $43 | $4 |
2013: 10 drugs
| Sensipar | 15 | $17,955 | $1,197 |
| Atorvastatin | 15 | $440 | $29 |
| Amlodipine Besylate | 26 | $205 | $8 |
| Pravastatin | 16 | $202 | $13 |
| Lisinopril | 24 | $182 | $8 |
| Metoprolol | 11 | $148 | $13 |
| Carvedilol | 14 | $143 | $10 |
| Spironolactone | 19 | $117 | $6 |
| Furosemide | 19 | $86 | $5 |
| Allopurinol | 11 | $35 | $3 |
Money from drug and device companies
$137 in 2025
| 2025 | 2 | 2 | None | $137 |
| 2023 | 3 | 5 | None | $194 |
| 2022 | 1 | 5 | None | $162 |
| 2021 | 1 | 3 | None | $183 |
| 2020 | 1 | 1 | None | $12 |
| 2019 | 2 | 2 | None | $214 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Amgen | Meals · 2025-12-04 | Krystexxa | $14 |
| Ardelyx | Meals · 2025-04-29 | Xphozah 30 Mg | $123 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $194
| AstraZeneca Pharmaceuticals LP | Farxiga | $115 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $60 | 3 payments
|
| Boston Scientific | Bodyguardian | $18 | 1 payment
|
2022: $162
| Horizon Therapeutics plc | Krystexxa | $162 | 5 payments
|
2021: $183
| Horizon Therapeutics plc | Krystexxa | $183 | 3 payments
|
2020: $12
| Fresenius USA Marketing | Velphoro | $12 | 1 payment
|
2019: $214
| Baxter Healthcare | Renal - Non Product Related | $122 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $91 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 16.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1346485315
- Licence
- CA A105269California A105269: Current · expires 2028-02-29
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 960 E Green St Ste 107, Pasadena, CA, 91106
- NPI first listed
- 2008-12-04
- NPI last updated
- 2024-01-22
- NPI record certified
- 2024-01-22
This is when the NPI record was last certified, not a medical board exam.